Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yaqian Huo"'
Autor:
Fan Gao, Pei Liu, Yaqian Huo, Lianlian Bian, Xing Wu, Mingchen Liu, Qian Wang, Qian He, Fangyu Dong, Zejun Wang, Zhongping Xie, Zhongyang Zhang, Meirong Gu, Yingzhi Xu, Yajing Li, Rui Zhu, Tong Cheng, Tao Wang, Qunying Mao, Zhenglun Liang
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
ABSTRACTThe increasing incidence of diseases caused by Coxsackievirus A6 (CV-A6) and the presence of various mutants in the population present significant public health challenges. Given the concurrent development of multiple vaccines in China, it is
Externí odkaz:
https://doaj.org/article/7dd415f2eb8a4a48ae6dd988492fc708
Autor:
Yaqian Huo, Jinghuan Yang, Pei Liu, Bopei Cui, Chenfei Wang, Siyuan Liu, Fangyu Dong, Xujia Yan, Lianlian Bian, Fan Gao, Xing Wu, Jiuyue Zhou, Tong Cheng, Xiuling Li, Qunying Mao, Zhenglun Liang
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 12, Pp 5334-5347 (2021)
Increased severity of diseases caused by Coxsackievirus A10 (CV-A10) as well as a large number of mutants and recombinants circulating in the population are a cause of concern for public health. A vaccine with broad-spectrum and homogenous protective
Externí odkaz:
https://doaj.org/article/2828478450c84a16ad8aefe22e8afe9c
Autor:
Jialu Zhang, Qian He, Chaoqiang An, Qunying Mao, Fan Gao, Lianlian Bian, Xing Wu, Qian Wang, Pei Liu, Lifang Song, Yaqian Huo, Siyuan Liu, Xujia Yan, Jinghuan Yang, Bopei Cui, Changgui Li, Junzhi Wang, Zhenglun Liang, Miao Xu
Publikováno v:
Emerging Microbes and Infections, Vol 10, Iss 1, Pp 1598-1608 (2021)
Since the outbreak of COVID-19, a variety of vaccine platforms have been developed. Amongst these, inactivated vaccines have been authorized for emergency use or conditional marketing in many countries. To further enhance the protective immune respon
Externí odkaz:
https://doaj.org/article/6ca2e1b1c0384e60bd549b6e0ea96bb9
Autor:
Pei Liu, Yadi Yuan, Bopei Cui, Yaqian Huo, Lianlian Bian, Lei Chen, Siyuan Liu, Chenfei Wang, Yingzhi Xu, Alison Tedcastle, Fan Gao, Qunying Mao, Javier Martin, Zhenglun Liang
Publikováno v:
Viruses, Vol 13, Iss 5, p 720 (2021)
Enterovirus A-71 (EV71) is a global, highly contagkkious pathogen responsible for severe cases of hand-food-mouth-disease (HFMD). The use of vaccines eliciting cross neutralizing antibodies (NTAbs) against the different circulating EV71 sub-genotypes
Externí odkaz:
https://doaj.org/article/16c32e7b2146475ca70c0c5389684126
Autor:
Xujia Yan, Bopei Cui, Yaqian Huo, Zhenglun Liang, Jiuyue Zhou, Jinghuan Yang, Pei Liu, Lianlian Bian, Chenfei Wang, Tong Cheng, Xing Wu, Fan Gao, Xiu-Ling Li, Fangyu Dong, Siyuan Liu, Qunying Mao
Publikováno v:
Human Vaccines & Immunotherapeutics. 17:5334-5347
Increased severity of diseases caused by Coxsackievirus A10 (CV-A10) as well as a large number of mutants and recombinants circulating in the population are a cause of concern for public health. A vaccine with broad-spectrum and homogenous protective
Autor:
Pei Liu, Qian He, Xujia Yan, Miao Xu, Fan Gao, Siyuan Liu, Chaoqiang An, Changgui Li, Bopei Cui, Yaqian Huo, Qian Wang, Zhenglun Liang, Xing Wu, Jinghuan Yang, Junzhi Wang, Qunying Mao, Lianlian Bian, Lifang Song, Jialu Zhang
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Since the outbreak of COVID-19, a variety of vaccine platforms have been developed. Amongst these, inactivated vaccines have been authorized for emergency use or conditional marketing in many countries. To further enhance the protective immune respon
Autor:
Javier Martin, Yaqian Huo, Qunying Mao, Fan Gao, Yingzhi Xu, Alison Tedcastle, Bopei Cui, Siyuan Liu, Chenfei Wang, Zhenglun Liang, Pei Liu, Lianlian Bian, Lei Chen, Yadi Yuan
Publikováno v:
Viruses
Volume 13
Issue 5
Viruses, Vol 13, Iss 720, p 720 (2021)
Volume 13
Issue 5
Viruses, Vol 13, Iss 720, p 720 (2021)
Enterovirus A-71 (EV71) is a global, highly contagkkious pathogen responsible for severe cases of hand-food-mouth-disease (HFMD). The use of vaccines eliciting cross neutralizing antibodies (NTAbs) against the different circulating EV71 sub-genotypes